Literature DB >> 28965530

Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes.

Stephen M Stahl.   

Abstract

Drugs for psychosis and mood that bind dopamine D2 receptors can be classified not only by whether they also block serotonin 2A receptors, but by whether they also bind D3 or D1 receptors.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28965530     DOI： 10.1017/S1092852917000608

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


  14 in total

Review 1.  Come Fly with Me: An overview of dopamine receptors in Drosophila melanogaster.

Authors:  Caline S Karam; Sandra K Jones; Jonathan A Javitch
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-07-09       Impact factor: 4.080

Review 2.  Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy.

Authors:  Leslie Citrome
Journal:  Neuropsychiatr Dis Treat       Date:  2018-10-05       Impact factor: 2.570

Review 3.  Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders.

Authors:  Béla Kiss; István Laszlovszky; Balázs Krámos; András Visegrády; Amrita Bobok; György Lévay; Balázs Lendvai; Viktor Román
Journal:  Biomolecules       Date:  2021-01-14

4.  New information of dopaminergic agents based on quantum chemistry calculations.

Authors:  Guillermo Goode-Romero; Ulrika Winnberg; Laura Domínguez; Ilich A Ibarra; Rubicelia Vargas; Elisabeth Winnberg; Ana Martínez
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

5.  Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies.

Authors:  Ágota Barabássy; Barbara Sebe; Károly Acsai; István Laszlovszky; Balázs Szatmári; Willie R Earley; György Németh
Journal:  Neuropsychiatr Dis Treat       Date:  2021-04-07       Impact factor: 2.570

Review 6.  Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment?

Authors:  Ariel Frajerman; Linda Scoriels; Oussama Kebir; Boris Chaumette
Journal:  Int J Mol Sci       Date:  2021-06-26       Impact factor: 5.923

Review 7.  Moderators and mediators of antipsychotic response in delusional disorder: Further steps are needed.

Authors:  Alexandre González-Rodríguez; Armand Guàrdia; Diego José Palao; Javier Labad; Mary V Seeman
Journal:  World J Psychiatry       Date:  2020-04-19

Review 8.  Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment.

Authors:  Christoph U Correll; Nina R Schooler
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-21       Impact factor: 2.570

Review 9.  Cariprazine as a treatment across the bipolar I spectrum from depression to mania: mechanism of action and review of clinical data.

Authors:  Stephen M Stahl; Sarah Laredo; Debbi Ann Morrissette
Journal:  Ther Adv Psychopharmacol       Date:  2020-02-12

Review 10.  The role of dopamine receptors in lymphocytes and their changes in schizophrenia.

Authors:  M A Penedo; T Rivera-Baltanás; D Pérez-Rodríguez; J Allen; A Borrajo; D Alonso-Crespo; C Fernández-Pereira; M Nieto-Araujo; S Ramos-García; C Barreiro-Villar; H J Caruncho; J M Olivares; R C Agís-Balboa
Journal:  Brain Behav Immun Health       Date:  2021-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.